Edwards Lifesciences Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Edwards Lifesciences (EW) PT Raised to $260 at RBC Capital
October 24, 2019 6:25 AM EDTRBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $260.00 (from $250.00) while maintaining an Outperform rating.
US TAVR growth of +30%"We now model 2019 and 2020 revenues of $4.32B (previously $4.22B) and $4.74B (previously $4.64B), respectively. Moving to the... MoreEdwards Lifesciences (EW) Tops Q3 EPS by 19c, Updates FY Guidance
October 23, 2019 4:20 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $1.41, $0.19 better than the analyst estimate of $1.22. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.50-$5.65, versus the consensus of $5.34.... More
